The Class I Self-Certification Pathway: How Manufacturers Can Achieve EU Market Access Without a Notified Body
Accessing the EU medical device market often means navigating notified body bottlenecks and incurring high audit fees. For manufacturers of standard Class I devices, however, there’s a faster route to Class I MDR certification through the self-certification pathway under EU MDR.
This pathway allows eligible manufacturers to declare conformity independently. It still requires the same rigorous compliance as devices that undergo independent assessment, and the responsibility shifts to the manufacturer.
What Self-Certification Means Under EU MDR
The self-certification pathway under EU MDR allows manufacturers of standard Class I devices to declare conformity without involving a notified body. These are nonsterile devices without a measuring function, not surgical tools, intended for reprocessing and repeated use. Class I devices supplied sterile, used for measuring or intended for reprocessing as surgical tools (Class Is, Im and Ir) need notified body involvement for those specific aspects. Standard Class I devices, however, can self-declare conformity under the regulation without that step.
Under this pathway, the manufacturer assumes full legal responsibility for demonstrating that MDR Class I medical devices meet the General Safety and Performance Requirements (GSPR) outlined in the regulation. Self-certification removes external review of the device itself, but manufacturers must still build and maintain the infrastructure to support that declaration.
Who Benefits Most From Self-Certification
The fast-track self-certification pathway offers clear advantages for manufacturers with the internal capacity to manage compliance independently. Manufacturers already hold prime responsibility for CE marking under EU rules, and this pathway keeps the declaration in their hands. Speed is the most obvious benefit. There are no queue times for notified body slots, and manufacturers can control the timeline from development to market entry. Cost savings follow closely behind, as skipping third-party assessment fees can significantly reduce the financial burden.
The cost of this autonomy, however, is internal workload. Manufacturers must have the personnel, systems and expertise to compile technical documentation, conduct clinical evaluations and manage post-market surveillance without external guidance. For organizations with strong regulatory and quality functions, self-certification can deliver both efficiency and autonomy.
What “Doing It Yourself” Actually Involves
Self-certification is a structured compliance process that manufacturers execute independently. The pathway includes the following steps:
- Confirm the device’s classification under MDR Annex VIII.
- Establish a quality management system (QMS) per MDR Article 10(9) that addresses design, manufacturing and post-market activities.
- Compile technical documentation per Annexes II and III, including risk management files, labeling specifications and evidence of GSPR conformity.
- Conduct a clinical evaluation, often literature-based for Class I devices, to demonstrate safety and performance.
- Designate a person responsible for regulatory compliance (PRRC) in accordance with MDR Article 15.
- Draft the EU Declaration of Conformity and affix the CE mark.
- Register the manufacturer and device in EUDAMED and implement a post-market surveillance system.
Each step requires documented information, internal resources and ongoing oversight, and Medical Device Coordination Group guidance documents explain how to apply the regulation in practice.
Where Self-Certification Breaks Down
Market surveillance authorities actively monitor the EU market, and self-declared files can draw heightened scrutiny precisely because no independent assessor reviewed them. Weak quality management systems and incomplete documented information are common failure points that can lead to corrective action requests or market withdrawal.
Having an accredited certification body verify your QMS before you self-declare the device can help demonstrate that your infrastructure is in place and capable of supporting long-term compliance.
How NQA Assesses Your QMS Readiness for ISO 13485
Manufacturers seeking that verification can turn to National Quality Assurance (NQA), an accredited certification body with head offices in the UK, U.S. and China. NQA certifies organizations to ISO 13485, the international standard for medical device quality management systems, which closely aligns with the QMS requirements of the EU MDR and supports Class I medical device compliance.
NQA’s accredited ISO 13485 certification services assess your documented information against the standard, and its readiness assessments evaluate whether your quality system can support independent compliance management. NQA also reviews and validates technical files, checking that they are complete, consistent and traceable before you issue your Declaration of Conformity.
Every NQA audit also identifies opportunities for improvement, and certification to ISO 13485 can enhance risk management and provide proven business credentials. For devices that require a notified body, Kiwa is the notified body that allows NQA to offer MDR certification.
Why Verified Quality Systems Support Long-Term EU Access
Self-certification offers speed, cost efficiency and autonomy for manufacturers of nonsterile Class I devices without a measuring function. This autonomy works best when a verified QMS supports it, demonstrating to market surveillance authorities that your infrastructure can sustain compliance over the device life cycle. Certification to ISO 13485 through NQA is one way to verify that foundation.
*Please note that this list includes sponsored content. Some of the companies, products, or services featured have entered into commercial agreements for placement. Sponsored placements do not necessarily reflect an endorsement and should be considered alongside other options in the marketplace.